|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/198 | |
| A61K 31/195 | |||
| A61K 31/275 | |||
| A61K 31/138 | |||
| A61K 31/345 | |||
| A61K 45/06 |
| (11) | Patento numeris | 2167066 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08769311.5 |
| Europos patento paraiškos padavimo data | 2008-05-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-03-31 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-06-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/062879 |
| Data | 2008-05-07 |
| (87) | Numeris | WO 2008/137923 |
| Data | 2008-11-13 |
| (30) | Numeris | Data | Šalis |
| 916497 P | 2007-05-07 | US |
| (72) |
ROBERTS, Michael, J., US
PEDDER, Simon, US
|
| (73) |
Chelsea Therapeutics, Inc.,
3530 Toringdon Way Suite 200, Charlotte, NC 28277,
US
|
| (54) | DROXIDOPA AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF ATTENTION DEFICIT DISORDERS |
| DROXIDOPA AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF ATTENTION DEFICIT DISORDERS |